[go: up one dir, main page]

NO301805B1 - Fremgangsmåte for fremstilling av et stabilt, galenisk, vandig preparat av erytropoietin - Google Patents

Fremgangsmåte for fremstilling av et stabilt, galenisk, vandig preparat av erytropoietin

Info

Publication number
NO301805B1
NO301805B1 NO911788A NO911788A NO301805B1 NO 301805 B1 NO301805 B1 NO 301805B1 NO 911788 A NO911788 A NO 911788A NO 911788 A NO911788 A NO 911788A NO 301805 B1 NO301805 B1 NO 301805B1
Authority
NO
Norway
Prior art keywords
preparation
erythropoietin
aqueous
physiologically tolerated
epo
Prior art date
Application number
NO911788A
Other languages
English (en)
Other versions
NO911788L (no
NO911788D0 (no
Inventor
Dieter Brazel
Bernhard Siebold
Dorothee Krumwieh
Thomas Brune
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of NO911788D0 publication Critical patent/NO911788D0/no
Publication of NO911788L publication Critical patent/NO911788L/no
Publication of NO301805B1 publication Critical patent/NO301805B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO911788A 1990-05-08 1991-05-07 Fremgangsmåte for fremstilling av et stabilt, galenisk, vandig preparat av erytropoietin NO301805B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014654A DE4014654A1 (de) 1990-05-08 1990-05-08 Galenische waessrige formulierungen von erythropoietin und ihre verwendung

Publications (3)

Publication Number Publication Date
NO911788D0 NO911788D0 (no) 1991-05-07
NO911788L NO911788L (no) 1991-11-11
NO301805B1 true NO301805B1 (no) 1997-12-15

Family

ID=6405907

Family Applications (1)

Application Number Title Priority Date Filing Date
NO911788A NO301805B1 (no) 1990-05-08 1991-05-07 Fremgangsmåte for fremstilling av et stabilt, galenisk, vandig preparat av erytropoietin

Country Status (13)

Country Link
EP (1) EP0456153B1 (no)
JP (1) JP2922331B2 (no)
KR (1) KR100203546B1 (no)
AT (1) ATE120646T1 (no)
AU (1) AU652361B2 (no)
CA (1) CA2041989C (no)
DE (2) DE4014654A1 (no)
DK (1) DK0456153T3 (no)
ES (1) ES2073063T3 (no)
IE (1) IE65925B1 (no)
NO (1) NO301805B1 (no)
PT (1) PT97584B (no)
ZA (1) ZA913435B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9917606A (pt) 1998-11-06 2002-12-31 Bio Sidus S A Procedimento para a purificação de eritropoetina humana recombinante a partir de sobrenadantes de cultivo de células e eritropoetina humana recombinante obtida com tal procedimento
MXPA02011303A (es) 2000-05-15 2003-04-25 Hoffmann La Roche Nueva composicion farmaceutica.
DE10234192B4 (de) 2002-07-26 2009-11-26 Epoplus Gmbh Co.Kg Verwendung von Erythropoetin
EP1537876A1 (en) * 2003-12-01 2005-06-08 BioGeneriX AG Erythropoietin solution formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57149228A (en) * 1981-03-11 1982-09-14 Ajinomoto Co Inc Novel erythropoietin and its preparation
JPH0686480B2 (ja) * 1983-02-21 1994-11-02 雪印乳業株式会社 エリスロポエチン製造用モノクローナル抗体
JPS6191131A (ja) * 1984-10-09 1986-05-09 Chugai Pharmaceut Co Ltd 医薬品の吸着防止方法および組成物
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate

Also Published As

Publication number Publication date
JP2922331B2 (ja) 1999-07-19
ES2073063T3 (es) 1995-08-01
PT97584B (pt) 1998-08-31
DK0456153T3 (da) 1995-08-07
AU7618391A (en) 1991-11-14
DE59105075D1 (de) 1995-05-11
CA2041989C (en) 2001-07-31
KR100203546B1 (ko) 1999-06-15
DE4014654A1 (de) 1991-11-14
IE911549A1 (en) 1991-11-20
KR910019636A (ko) 1991-12-19
ATE120646T1 (de) 1995-04-15
NO911788L (no) 1991-11-11
EP0456153A1 (de) 1991-11-13
CA2041989A1 (en) 1991-11-09
EP0456153B1 (de) 1995-04-05
IE65925B1 (en) 1995-11-29
ZA913435B (en) 1992-02-26
PT97584A (pt) 1992-01-31
AU652361B2 (en) 1994-08-25
NO911788D0 (no) 1991-05-07
JPH04225923A (ja) 1992-08-14

Similar Documents

Publication Publication Date Title
UA26855C2 (uk) Фармацевтичhа композиція, яка регулює гематопоез
BR9709844A (pt) Preparação aquosa de insulina formulação farmacêutica parenteral usos de um carboidrato n o-redutor ou reduzido e de manitol sorbitol xilitol inositol trealose sacarose ou qualquer sua mistura e processo de fabricação de uma preparação de insulina
SE8402560L (sv) Farmaceutisk komposition
FI893783A0 (fi) Menetelmä diabetes mellituksen hoitoon tarkoitetun farmaseuttisen valmisteen valmistamiseksi
BR9709845A (pt) Preparação aquosa de insulina formulação farmacêutica parenteral e processo para aumentar a estabilidade química de uma preparação de insulina
DE69531314D1 (de) Verwendung von metallionen chelatoren zur stabilisierung von interferon-enthaltenden pharmazeutischen zubereitungen
FI863652A0 (fi) 7-isopropoxiisflavoninklusionskomplex bildat med cyklodextrin och ett foerfarande foer dess framstaellning.
NO170126C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater i form av suspensjoner som inneholder sucralfat
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
FI945549A0 (fi) Deoksiribonukleaasin puhdistetut muodot
DE69631881D1 (de) Pulmonale verabreichung von medikamenten in aerosolform
ATE121295T1 (de) Augentropfenarzneimittel.
DE68904922D1 (de) Piroxicam in waessrigen loesungen enthaltende arzneizubereitungen und verfahren zu deren herstellung.
NO922953L (no) Rekombinant fremstilt blodfaktorer og fremgangsmaate for ekspresjon av blodfaktorene, samt vacciniavirusrekombinanter
DE3767114D1 (de) Stabilisierte arzneimittel.
NO301805B1 (no) Fremgangsmåte for fremstilling av et stabilt, galenisk, vandig preparat av erytropoietin
KR910005886A (ko) 안정화 백혈구 인터페론
NO883520D0 (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
IT8620703A0 (it) Derivati dell'acido 4-fenil 4-osso 2-butenoico, loro procedimento di preparazione e loro impiego come prodotti medicinali.
FI880027A0 (fi) Antibakteriellt lyofiliserat preparat.
ATE132877T1 (de) Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung
IT1238210B (it) Esteri del cefamandolo nafato, procedimento per la loro preparazione erelative composizioni farmaceutiche.

Legal Events

Date Code Title Description
MK1K Patent expired